PerMed OÜ

Active Registry code 14584677 OÜ Tartu linn Registered 11 Oct 2018
Compare

PerMed OÜ is a OÜ based in Tartu linn, registry code 14584677, status: active. Main activity: Research and experimental development on natural sciences and engineering. Its annual report for 2025 shows revenue of €5 600 and 0 employees.

Turnover
—
State taxes
3 000 €
Labour taxes
0 €
Employees
—

Q1 2025 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 5 600 €
    industry median 0 € · companies in the industry: 1 073
  • Net profit margin · 2025 15.0 %
    industry median 13.5 % · companies in the industry: 597

Taxes and turnover

Q1 2025 – Q1 2025
State taxes, € Q1 2025: 3 000 €
01 0002 0003 000Q1 2025 Company: 3 000 €Q1·2501 0002 0003 000Q1 2025 Company: 3 000 €Q1·25
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q1 2025 — 3 000 — —

Financials by year

2019 – 2025
Revenue, € 2025: 5 600 € · +40.0% vs 2024 · industry median 0 € · above 65% of the industry
02 5005 0007 50010 00012 5002019 Company: 5 350 € Industry median: 0 €20192020 Company: 11 680 € Industry median: 150 €20202021 Company: 9 600 € Industry median: 0 €20212022 Company: 7 800 € Industry median: 103 €20222023 Company: 4 950 € Industry median: 76 €20232024 Company: 4 000 € Industry median: 0 €20242025 Company: 5 600 € Industry median: 0 €202502 5005 0007 50010 00012 5002019 Company: 5 350 € Industry median: 0 €20192020 Company: 11 680 € Industry median: 150 €2021 Company: 9 600 € Industry median: 0 €20212022 Company: 7 800 € Industry median: 103 €2023 Company: 4 950 € Industry median: 76 €20232024 Company: 4 000 € Industry median: 0 €2025 Company: 5 600 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 842 € · +130.9% vs 2024 · industry median 0 € · above 64% of the industry
-5 000-2 50002 5005 0007 50010 0002019 Company: 1 180 € Industry median: 3 €20192020 Company: 7 583 € Industry median: 28 €20202021 Company: 1 574 € Industry median: 1 €20212022 Company: 1 601 € Industry median: 0 €20222023 Company: 2 833 € Industry median: 0 €20232024 Company: -2 727 € Industry median: 0 €20242025 Company: 842 € Industry median: 0 €2025-5 000-2 50002 5005 0007 50010 0002019 Company: 1 180 € Industry median: 3 €20192020 Company: 7 583 € Industry median: 28 €2021 Company: 1 574 € Industry median: 1 €20212022 Company: 1 601 € Industry median: 0 €2023 Company: 2 833 € Industry median: 0 €20232024 Company: -2 727 € Industry median: 0 €2025 Company: 842 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 15.0 % · +83.2 pp vs the year before · industry median 13.5 % · above 51% of the industry
-100-500501002019 Company: 22.1 % Industry median: 12.7 %20192020 Company: 64.9 % Industry median: 23.8 %20202021 Company: 16.4 % Industry median: 25.1 %20212022 Company: 20.5 % Industry median: 17.7 %20222023 Company: 57.2 % Industry median: 16.8 %20232024 Company: -68.2 % Industry median: 15.8 %20242025 Company: 15.0 % Industry median: 13.5 %2025-100-500501002019 Company: 22.1 % Industry median: 12.7 %20192020 Company: 64.9 % Industry median: 23.8 %2021 Company: 16.4 % Industry median: 25.1 %20212022 Company: 20.5 % Industry median: 17.7 %2023 Company: 57.2 % Industry median: 16.8 %20232024 Company: -68.2 % Industry median: 15.8 %2025 Company: 15.0 % Industry median: 13.5 %2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 3 731 € · −33.1% vs 2024
05 00010 00015 0002019 Company: 1 203 €20192020 Company: 9 126 €20202021 Company: 10 781 €20212022 Company: 11 979 €20222023 Company: 14 770 €20232024 Company: 5 577 €20242025 Company: 3 731 €202505 00010 00015 0002019 Company: 1 203 €20192020 Company: 9 126 €2021 Company: 10 781 €20212022 Company: 11 979 €2023 Company: 14 770 €20232024 Company: 5 577 €2025 Company: 3 731 €2025
Equity, € 2025: 3 385 € · +33.1% vs 2024
05 00010 00015 0002019 Company: 1 180 €20192020 Company: 8 762 €20202021 Company: 10 336 €20212022 Company: 11 937 €20222023 Company: 14 770 €20232024 Company: 2 543 €20242025 Company: 3 385 €202505 00010 00015 0002019 Company: 1 180 €20192020 Company: 8 762 €2021 Company: 10 336 €20212022 Company: 11 937 €2023 Company: 14 770 €20232024 Company: 2 543 €2025 Company: 3 385 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 120202021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 12021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 5 600 842 0 3 731 3 385 0
2024 4 000 -2 727 0 5 577 2 543 0
2023 4 950 2 833 0 14 770 14 770 0
2022 7 800 1 601 0 11 979 11 937 0
2021 9 600 1 574 0 10 781 10 336 0
2020 11 680 7 583 0 9 126 8 762 0
2019 5 350 1 180 0 1 203 1 180 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
15.0 %
Net profit / revenue
Return on equity (ROE)
24.9 %
Net profit / equity
Return on assets (ROA)
22.6 %
Net profit / assets
Equity ratio
90.7 %
Equity / assets
Debt ratio
9.3 %
Liabilities / assets
Current ratio
10.78
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 27 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 12 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 9 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 31 May 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 27 Jun 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 22 Jun 2021 Company’s own e-Äriregister
2019 11 Oct 2018 – 31 Dec 2019 30 Oct 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72101Research and experimental development on natural sciences and engineering Main

Rulings 6

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50104370 / 5
23 May 2025
 Amendment entry In force
23 May 2025
 PDF
Ä 50104370 / 4
20 May 2025
 Amendment entry In force
20 May 2025
 PDF
Ä 50104370 / 3
2 Sep 2023
 Amendment entry In force
2 Sep 2023
 PDF
Ä 50104370 / 2
3 Aug 2020
 Amendment under Commercial Code § 525 (2) In force
3 Aug 2020
 PDF
Ä 50104370
11 Oct 2018
 First entry In force
11 Oct 2018
 PDF
Ä 50104370 / M1
9 Oct 2018
 Ruling to eliminate deficiencies 8 Nov 2018 Deficiencies eliminated
11 Oct 2018
 PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data